Praxis Precision Medicines PRAX
NASDAQ PRAX
$256.47 -8.02 (-3.03%)
At close: Oct 21, 2026 · 4:00 PM EDT

Praxis Precision Medicines (PRAX) Cash from Financing Activities (2019 - 2026)

Updated

Praxis Precision Medicines (PRAX) posted Cash from Financing Activities of $4.57 million for Q2 2026, down 84.0% from $28.63 million a year earlier and down 99.2% from the prior quarter.

Analysis

Praxis Precision Medicines (PRAX) Cash from Financing Activities (2019 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Cash from Financing Activities at Praxis Precision Medicines was $1.23 billion, up 522.5% year-over-year; for FY2025, it came in at $702.17 million, up 36.5% from FY2024.

  • Annual Cash from Financing Activities has increased for three consecutive years, with a five-year compound annual growth rate of 18.2% (FY2020 to FY2025).
  • In prior years, Praxis Precision Medicines' Cash from Financing Activities was $514.32 million in FY2024 (+459.8%), $91.87 million in FY2023 (+777.9%), $10.47 million in FY2022 (-90.3%) and $107.59 million in FY2021 (-64.7%).
  • The Q2 2026 figure stands as the lowest quarterly Cash from Financing Activities since Q3 2024.
  • On a year-over-year basis, Cash from Financing Activities increased in two of the last five quarters, with growth averaging 113.6%.
  • The strongest year-over-year quarter for Cash from Financing Activities in the past five years was Q1 2024, with growth of 911.4%; the weakest was Q3 2021, with a decline of 99.8%.
  • According to Business Quant data, Cash from Financing Activities for the three prior quarters was $609.43 million (Q1 2026), $612.52 million (Q4 2025) and $6.76 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 8.43 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn -8.78 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -5.05 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 1.76 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -2.02 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -3.89 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -1.48 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 2.34 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -3.66 Bn
10 Praxis Precision Medicines 7.47 Bn 5.06 Bn - 4.57 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.57 Mn
Mar 31, 2026 609.43 Mn
Dec 31, 2025 612.52 Mn
Sep 30, 2025 6.76 Mn
Jun 30, 2025 28.63 Mn
Mar 31, 2025 54.27 Mn
Dec 31, 2024 113.77 Mn
Sep 30, 2024 1.44 Mn
Jun 30, 2024 216.36 Mn
Mar 31, 2024 182.76 Mn
Dec 31, 2023 4.13 Mn
Jun 30, 2023 69.68 Mn
Mar 31, 2023 18.07 Mn
Dec 31, 2022 5.39 Mn
Sep 30, 2022 3.37 Mn
Jun 30, 2022 504,000.00
Mar 31, 2022 1.21 Mn
Dec 31, 2021 7.71 Mn
Sep 30, 2021 212,000.00
Jun 30, 2021 99.39 Mn
API Access

Praxis Precision Medicines Cash from Financing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=PRAX&period=max&api_key=YOUR_API_KEY